Gyre Therapeutics, Inc. · NASDAQ:GYRE

Ye Weiguo sold 20,918 Gyre Therapeutics, Inc. shares (Form 4)

Traded Jun 9 to Jun 10, 2026 · Filed Jun 11, 2026

From Jun 9 to Jun 10, 2026, Ye Weiguo (Chief Operating Officer) sold 20,918 Gyre Therapeutics, Inc. shares at an average US$6.16 for US$129K, leaving 700,000 shares. Filed Jun 11, 2026 (Form 4).

Sold
20,918 shares
Price
US$6.16 average (US$6.14 to US$6.21)
Value
US$129K
Holding after
700,000 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 9, 2026Common StockOption exercise14,500US$0.75714,500Direct
Jun 9, 2026Common StockSale14,500US$6.14700,000Direct
Jun 10, 2026Common StockOption exercise6,418US$0.75706,418Direct
Jun 10, 2026Common StockSale6,418US$6.21700,000Direct

Source

View original at SEC

Related